digplanet beta 1: Athena
Share digplanet:


Applied sciences






















G. V. Prasad
జి.వి. ప్రసాద్
Residence Hyderabad, India
Nationality Indian
Ethnicity Telugu, Andhraite
Alma mater Purdue University
Illinois Institute of Technology
Alagappa College of Technology
Occupation CEO of Dr. Reddy's Laboratories
Religion Hindu
Relatives Kallam Anji Reddy (father-in-law)
Kallam Satish Reddy (brother-in-law)

G. V. Prasad (Telugu: జి.వి. ప్రసాద్) is an Indian business executive, and CEO of Dr. Reddy's Laboratories.[1][2] Prasad studied Chemical Engineering at the Alagappa College of Technology. After completing five semesters, he went on to the Illinois Institute of Technology in Chicago to complete the three remaining semesters. Prasad followed up the engineering degree with a one-year MBA at Purdue University. He won the 'Outstanding Senior Student' Award from the American Institute of Chemists, Chicago chapter in 1982. He earned his Masters in Industrial Administration from Purdue University a year later.[3]

His first exposure to the world of pharmaceuticals was in 1985 with Benzex Labs, a pharmaceutical enterprise that he co-founded. Benzex was later acquired by Dr. Reddys and Prasad returned to the construction business, only to come back to pharmaceuticals in 1990 – this time as the CEO and MD of Cheminor Drugs Ltd. In 2001, Cheminor Drugs merged with Dr.Reddy's Laboratories[4] and Prasad took over as the vice-chairman and CEO of the merged entity.[5]

Early life[edit]

Prasad, the second child of Syamala and Harischandra Reddy,[6] did his initial schooling at the Vidyaranya High School in Hyderabad, Andhra Pradesh, India. He later moved to his hometown, Nellore, where he finished his schooling at VR High School.[7]

Personal life[edit]

Prasad is married to Anuradha, the daughter of Kallam Anji Reddy, who is the founder of Dr Reddy's Labs.[8] Anuradha is the managing trustee of Dr Reddy's Foundation as well as the founder-director of Saptaparni, an organisation promoting the traditions and culture of India.[9]

Early career[edit]

After completing his Masters, Prasad returned to India and joined his father's construction business, immersing himself in various projects in Karnataka. In 1985, he co-founded Benzex Labs, an API manufacturing company, which was later acquired by Dr Reddy's. He briefly returned to the construction business before reappearing on the pharma landscape in 1990 as managing director of Cheminor Drugs Ltd. Fueled by a spirit of entrepreneurship, Prasad transformed Cheminor into a world class API and Generics manufacturer, largely through his focus on professionalism, good governance and transparency.

In 2001, Cheminor Drugs merged with Dr.Reddy's Laboratories and Prasad took over as the vice-chairman and CEO of the merged entity. Prasad is widely credited as the architect of Dr. Reddy's successful global generics strategy. He envisioned newer business platforms like the Custom Pharmaceutical business and Specialty pharmaceuticals and is dedicated to building the innovation side of the business.

Professional affiliations[edit]

  • AP State Committee, WWF-India
  • Member of the Advisory Board, Acumen Fund
  • Member of the Board, Infotech Enterprises Ltd.
  • Member of the Board, Diana Hotels, India
  • Member of the Board, Ocimum Bio Solutions
  • Member, American Chemical Society
  • Member, American Institute of Chemical Engineers
  • Served as Chairman of the CII National Committee on Environment and the Intellectual Property Committee (2006–2007)


External links[edit]

Original courtesy of Wikipedia: http://en.wikipedia.org/wiki/G._V._Prasad — Please support Wikipedia.
This page uses Creative Commons Licensed content from Wikipedia. A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia.

743 news items

Economic Times
Wed, 26 Aug 2015 08:11:15 -0700

SANGAREDDY (TELANGANA): India should allow international educational institutes to operate in India, G V Prasad, co-chairman and CEO of DR Reddy's Lab, said here today. Indian students go abroad for higher studies and settle down there, which was a ...
Business Standard
Fri, 07 Aug 2015 07:06:57 -0700

As it expands its generics business, Dr Reddy's Laboratories is also looking for innovative ideas in allied areas. The company is planning investments in new ventures such as digital health and genomics, says Dr Reddy's co-chairman and chief executive ...

India Education Diary

India Education Diary
Wed, 26 Aug 2015 08:11:15 -0700

Addressing the 200 plus gathering of management students and faculty, G.V. Prasad said “I have three passions—1.Dr. Reddy Laboratories, where I work, 2. Nature and 3. Education. Education is the going to be the big differentiator in this competitive ...

Hindu Business Line

Hindu Business Line
Wed, 05 Aug 2015 11:00:00 -0700

Dr Reddy's Laboratories is keen on getting into new ventures related to health and is open to incubating ideas in this space. The drug-maker will look at new ventures in digital health, drug delivery technology and nutrition, GV Prasad, Dr Reddy's ...


Economic Times
Sat, 29 Aug 2015 07:15:00 -0700

Later speaking to reporters, GV Prasad - Dr Reddy's Laboratories co-chairman and chief executive officer said DRILS, which was incorporated in 2004, is working with over 20 pharma companies from India as well as abroad in their research projects.

Financial Express

Financial Express
Mon, 31 Aug 2015 04:37:35 -0700

The event was attended by YS Chowdary, Union Minister of State, Ministry of Science & Technology & Earth Sciences, Dilip Shanghvi, Founder and Managing Director, Sun Pharma, Satish Reddy, Chairman, Dr Reddy's Laboratories and GV Prasad, ...

The Hindu

The Hindu
Sat, 29 Aug 2015 17:00:00 -0700

In a media briefing that followed the inauguration, G V Prasad, CEO of Dr. Reddy's Laboratories said that DRILS will offer industry partners incubation facilities for drug discovery. The research at the institute, so far has been supported by union ...


Thu, 27 Aug 2015 03:12:56 -0700

When customers consolidate, “their bargaining power goes up,” said G.V. Prasad, chief executive officer (CEO) of Dr. Reddy's. “When three companies own 80% of the market, one of them can make a huge shift to your business.” Dr. Reddy's share in generic ...

Oops, we seem to be having trouble contacting Twitter

Support Wikipedia

A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia. Please add your support for Wikipedia!

Searchlight Group

Digplanet also receives support from Searchlight Group. Visit Searchlight